# BioNexus Gene Lab Corp: Form 8-K, filed Jun 5, 2026

- Company: [BioNexus Gene Lab Corp](/companies/bglc.md) (CIK 1737523)
- Form: 8-K
- Filed: 2026-06-05
- Accepted by EDGAR: Jun 5, 2026, 13:00 ET
- Period: 2026-05-29
- Accession: 0001477932-26-003658
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1737523/000147793226003658/bglc_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1737523/000147793226003658/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1737523/000147793226003658/bglc_8k.htm

Filed Jun 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001477932-26-003658. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.